Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0002061539-25-000001
Filing Date
2025-03-19
Accepted
2025-03-19 17:46:46
Documents
1
Period of Report
2025-01-28

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 3  
1 PRIMARY DOCUMENT primary_doc.xml 3 1501
  Complete submission text file 0002061539-25-000001.txt   3305
Mailing Address 12117 BEE CAVES ROAD BUILDING THREE SUITE 100 AUSTIN TX 78738
Business Address 12117 BEE CAVES ROAD BUILDING THREE SUITE 100 AUSTIN TX 78738 512-519-0400
Aspira Women's Health Inc. (Issuer) CIK: 0000926617 (see all company filings)

EIN.: 330595156 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
(CF Office: 03 Life Sciences)

Mailing Address 12117 BEE CAVES RD BUILDING III, SUITE 100 AUSTIN TX 78738
Business Address
Buhle Michael William (Reporting) CIK: 0002061539 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-34810 | Film No.: 25753890